PLAY PODCASTS
Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance
Episode 124

Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

Listen as John D. Baxter, MD, shares the latest data and recommendations for initiating ART in patients with transmitted antiretroviral drug resistance.

Decera Clinical Education Infectious Disease Podcast · John D. Baxter MD

January 25, 202217m 33s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.

Listen as he gives his perspectives on:

  • Initial response to antiretroviral therapy during primary HIV infection with baseline resistance
  • Data from the START study on treatment-naive patients with transmitted drug resistance by region and drug class
  • Recommendations from the US Department of Health and Human Services and International AIDS Society–USA guidelines on baseline genotype testing for integrase strand transfer inhibitor resistance
  • Considerations for the use of second-generation integrase strand transfer inhibitors and darunavir with transmitted drug resistance
  • Cases of transmitted multidrug-resistant HIV in patients receiving pre-exposure prophylaxis

Presenter:
John D. Baxter, MD
Professor of Medicine
Division of Infectious Diseases
Department of Pathology
Cooper Medical School of Rowan University
Head, Division of Infectious Diseases
Cooper University Health Care
Camden, New Jersey

Follow along with the slides at:
https://bit.ly/3u7pjWq

See the entire program at: 
https://bit.ly/3fOl0XX

 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

dolutegravirtransmittedngsintegrase inhibitorbicnext-generation sequencingbaseline resistancedrug resistancepidtgtreatment-naïvedhhs guidelinesintegrase strand transfer inhibitorbictegravirantiretroviral therapytransmitted resistancedarunavirrapid initiationbaselinedrvart resistancerapid startmulti-drug resistantstart studymdrresistance substitutionstransmitted drug resistancetdrinstiresistanceartprotease inhibitorhiv
← All episodes of Decera Clinical Education Infectious Disease Podcast